PA
CRBP icon

Perceptive Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

Perceptive Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,667
Closed -$1.42M – 144
2017
Q4 		$1.42M Sell
6,667
-7,156
-52% -$1.53M 0.05% 95
2017
Q3 		$2.96M Sell
13,823
-27,260
-66% -$5.33M 0.11% 84
2017
Q2 		$7.76M Sell
41,083
-584
-1% -$115K 0.39% 56
2017
Q1 		$10.3M Hold
41,667
– – 0.59% 40
2016
Q4 		$10.6M Sell
41,667
-48,367
-54% -$11.1M 0.75% 32
2016
Q3 		$18.3M Sell
90,034
-16,633
-16% -$2.07M 1.18% 18
2016
Q2 		$9.57M Buy
106,667
+65,000
+156% +$5.1M 0.66% 37
2016
Q1 		$2.26M Hold
41,667
– – 0.2% 83
2015
Q4 		$2.06M Hold
41,667
– – 0.15% 73
2015
Q3 		$1.96M Buy
41,667
+12,667
+44% +$843K 0.16% 81
2015
Q2 		$2.68M Buy
+29,000
New +$2.92M 0.16% 88

Other funds holding CRBP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Perceptive Advisors's CRBP Position: Q1 2018 in Review

Perceptive Advisors sold out of Corbus Pharmaceuticals (CRBP) in Q1 2018, closing a stake of 6,667 shares — an estimated $1.42M sold.

Perceptive Advisors first reported a position in CRBP in Q2 2015 and held it in 11 quarters. The position peaked at $18.3M in Q3 2016. 81 funds tracked by Wall St. Rank hold CRBP as of Q1 2018.

  • Perceptive Advisors reported no remaining Corbus Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Perceptive Advisors sold 6,667 Corbus Pharmaceuticals shares in Q1 2018, an estimated $1.42M.
  • Perceptive Advisors first reported a position in Corbus Pharmaceuticals in Q2 2015 and held it in 11 quarters.
  • Perceptive Advisors's Corbus Pharmaceuticals position peaked at $18.3M in Q3 2016.
  • 81 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2018.

Based on Perceptive Advisors's 13F filing for Q1 2018, filed 15 May 2018.